246 related articles for article (PubMed ID: 10436784)
1. Invasion and metastasis in pancreatic cancer.
Ellenrieder V; Adler G; Gress TM
Ann Oncol; 1999; 10 Suppl 4():46-50. PubMed ID: 10436784
[TBL] [Abstract][Full Text] [Related]
2. The role of the plasminogen activation system in angiogenesis and metastasis.
Rabbani SA; Mazar AP
Surg Oncol Clin N Am; 2001 Apr; 10(2):393-415, x. PubMed ID: 11382594
[TBL] [Abstract][Full Text] [Related]
3. The biochemistry of cancer dissemination.
Price JT; Bonovich MT; Kohn EC
Crit Rev Biochem Mol Biol; 1997; 32(3):175-253. PubMed ID: 9239493
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell interactions with the extracellular matrix during invasion and metastasis.
Stetler-Stevenson WG; Aznavoorian S; Liotta LA
Annu Rev Cell Biol; 1993; 9():541-73. PubMed ID: 8280471
[TBL] [Abstract][Full Text] [Related]
5. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers in cancer patients. an update of their prognostic significance. Part II.
Agnantis NJ; Goussia AC; Batistatou A; Stefanou D
In Vivo; 2004; 18(4):481-8. PubMed ID: 15369189
[TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong PF; Nadesapillai AP
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
9. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
11. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.
Sawai H; Takeyama H; Yamamoto M; Furuta A; Funahashi H; Okada Y; Sato M; Tanaka M; Manabe T
J Surg Oncol; 2003 Jan; 82(1):51-6. PubMed ID: 12501168
[TBL] [Abstract][Full Text] [Related]
13. The integrin-extracellular matrix axis in pancreatic cancer.
Grzesiak JJ; Ho JC; Moossa AR; Bouvet M
Pancreas; 2007 Nov; 35(4):293-301. PubMed ID: 18090233
[TBL] [Abstract][Full Text] [Related]
14. The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells.
Funahashi H; Okada Y; Sawai H; Takahashi H; Matsuo Y; Takeyama H; Manabe T
J Surg Oncol; 2005 Jul; 91(1):77-83. PubMed ID: 15999351
[TBL] [Abstract][Full Text] [Related]
15. Integrins and tumor invasion.
Dedhar S
Bioessays; 1990 Dec; 12(12):583-90. PubMed ID: 2080913
[TBL] [Abstract][Full Text] [Related]
16. Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation.
Heino J
Int J Cancer; 1996 Mar; 65(6):717-22. PubMed ID: 8631580
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of tumour metastasis.
Meyer T; Hart IR
Eur J Cancer; 1998 Feb; 34(2):214-21. PubMed ID: 9741324
[No Abstract] [Full Text] [Related]
18. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
[TBL] [Abstract][Full Text] [Related]
19. Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions.
Ohtani H
Pathol Int; 1998 Jan; 48(1):1-9. PubMed ID: 9589457
[TBL] [Abstract][Full Text] [Related]
20. RA-XII inhibits tumour growth and metastasis in breast tumour-bearing mice via reducing cell adhesion and invasion and promoting matrix degradation.
Leung HW; Zhao SM; Yue GG; Lee JK; Fung KP; Leung PC; Tan NH; Lau CB
Sci Rep; 2015 Nov; 5():16985. PubMed ID: 26592552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
